Skip Navigation

IID-25.2 Data Details

IID-25.2 Reduce new hepatitis B infections among high-risk populations—Injection drug users

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Notifiable Diseases Surveillance System (NNDSS); Centers for Disease Control and Prevention, Public Health Surveillance and Informatics Program Office (CDC/PHSIPO)
Changed Since the Healthy People 2020 Launch
Baseline (Year)
285 (2007)
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Number of reported symptomatic hepatitis B cases among those who had a valid response (yes or no) to the question about injection drug use on CDC Viral Hepatitis Case Record for Reporting of Patients With Symptomatic Acute Viral Hepatitis, Form 53 1
Data Collection Frequency
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

A case definition for new symptomatic cases of hepatitis B is available from CDC.


Additional resources about the objective.

  1. CDC. Vaccination coverage among adolescents 13—17 years--- United States, 2007. MMWR 2008;57(40); 1100-1103
  2. Centers for Disease Control and Prevention (CDC). Case definitions for infectious conditions under public health surveillance.
  3. Daniels D, Grytdal S, Wasley A. Surveillance for acute viral hepatitis - United States, 2007. MMWR Surveillance Summary. May 22 2009;58(3):1-27.